mci 154 has been researched along with Metabolic Acidosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, Y; Kitada, Y; Narimatsu, A | 1 |
| Abe, Y; Kitada, Y; Narimatsu, A; Tobe, A | 1 |
2 other study(ies) available for mci 154 and Metabolic Acidosis
| Article | Year |
|---|---|
Beneficial effect of MCI-154, a cardiotonic agent, on ischemic contractile failure and myocardial acidosis of dog hearts: comparison with dobutamine, milrinone and pimobendan.
Topics: Acidosis; Animals; Cardiotonic Agents; Coronary Disease; Dobutamine; Dogs; Female; Hemodynamics; Hydrogen-Ion Concentration; Male; Milrinone; Myocardial Contraction; Pyridazines; Pyridones | 1992 |
MCI-154, a novel cardiotonic agent, reverses the acidic pH-induced decrease in responses of cardiac myofilaments to Ca++: comparison with sulmazole and pimobendan.
Topics: Acidosis; Actin Cytoskeleton; Animals; Calcium; Cardiotonic Agents; Guinea Pigs; Hydrogen-Ion Concentration; Imidazoles; Male; Muscle, Smooth, Vascular; Myocardial Contraction; Pyridazines | 1991 |